—

Lantheus Holdings Inc(LNTH)— 同类公司组

数据截至2026-10-09 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Lantheus Holdings Inc的Closelook综合评分为59/100,在同类公司组内排名第5位(共11家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
LNTH Lantheus Holdings Inc59687257info10.5%
KNSA Kiniksa Pharmaceuticals Ltd56945721ok3.8%
BHC.TO Bausch Health Companies Inc55657084info22%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895642ok6%
GALDY GALDERMA GROUP AG54455727info14.1%
ALM.MC Almirall S.A.53224469warn26.9%
FAGR.BR Fagron NV52405461info12.3%
HALO Halozyme Therapeutics Inc74939451ok5.5%
DXCM DexCom Inc66818038watch8.8%
ONC BeiGene, Ltd.63776232info8%
MEDP Medpace Holdings Inc63847430ok9.7%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-09

Quick answers

Lantheus Holdings Inc在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Kiniksa Pharmaceuticals Ltd (KNSA)、Bausch Health Companies Inc (BHC.TO)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、GALDERMA GROUP AG (GALDY)、Almirall S.A. (ALM.MC)、Fagron NV (FAGR.BR)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

LNTH相对同类公司的评分如何?

Lantheus Holdings Inc的综合评分为59/100,组内排名第5位(共11家),截至2026-10-09;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.